Cargando…
Possible autoimmune hemolytic anemia induced by secukinumab: a case report
Secukinumab, an anti-IL-17 monoclonal antibody, has been used to treat psoriasis and psoriatic arthritis since 2015. Several adverse events were reported, such as diarrhea, upper respiratory tract infection, middle ear infection, and neutropenia. Here we report a probable case of autoimmune hemolyti...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The African Field Epidemiology Network
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917466/ https://www.ncbi.nlm.nih.gov/pubmed/35317476 http://dx.doi.org/10.11604/pamj.2022.41.41.32191 |